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Abstract
Background: Total laryngectomy with or without adjuvant (chemo)radiation often induces speech, swallowing and
neck and shoulder problems. Speech, swallowing and shoulder exercises may prevent or diminish these problems.
The aim of the present paper is to describe the study, which is designed to investigate the effectiveness and cost-utility
of a guided self-help exercise program built into the application “In Tune without Cords” among patients treated with
total laryngectomy.
Methods/design: Patients, up to 5 years earlier treated with total laryngectomy with or without (chemo)radiation will
be recruited for participation in this study. Patients willing to participate will be randomized to the intervention or
control group (1:1). Patients in the intervention group will be provided access to a guided self-help exercise program
and a self-care education program built into the application “In Tune without Cords”. Patients in the control group will
only be provided access to the self-care education program. The primary outcome is the difference in swallowing
quality (SWAL-QOL) between the intervention and control group. Secondary outcome measures address speech
problems (SHI), shoulder disability (SDQ), quality of life (EORTC QLQ-C30, QLQ-H&N35 and EQ-5D), direct and indirect
costs (adjusted iMCQ and iPCQ measures) and self-management (PAM). Patients will be asked to complete these
outcome measures at baseline, immediately after the intervention or control period (i.e. at 3 months follow-up) and at
6 months follow-up.
Discussion: This randomized controlled trial will provide knowledge on the effectiveness of a guided self-help
exercise program for patients treated with total laryngectomy. In addition, information on the value for money of
such an exercise program will be provided. If this guided self-help program is (cost)effective for patients treated
with total laryngectomy, the next step will be to implement this exercise program in current clinical practice.
Trial registration: NTR5255 Protocol version 4 date September 2015.
Keywords: Exercise program, Total laryngectomy, Head and neck cancer, Swallowing problems, Speech
problems, Shoulder problems
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Background
In the Netherlands, approximately 700 persons are diag-
nosed with laryngeal cancer each year and an additional
600 persons are diagnosed with hypopharyngeal cancer [1].
Depending on primary tumor location and tumor size,
patients with laryngeal cancer are treated with (laser)sur-
gery or (chemo)radiation preserving the larynx or, in case
of advanced tumors or tumors with extra laryngeal growth,
treated with total laryngectomy (TL) (i.e. resection of the
entire larynx). Hypopharyngeal cancer with laryngeal in-
volvement can also be treated with TL. About 150 patients
are treated with TL each year either as primary treatment,
often in combination with adjuvant (chemo)radiation, or
for recurrent disease after prior larynx-preserving treat-
ment (salvage laryngectomy) [2].
Patients treated with total laryngectomy often report
speech, swallowing and shoulder problems [3–6]. These
problems may give rise to emotional distress and de-
crease quality of life of patients [7, 8]. Scores on several
quality of life scales, such as dyspnoea, speech and social
contact, are still diminished 1 year after TL [9].
Several studies investigated the effectiveness of swal-
lowing and shoulder exercises targeting swallowing
and shoulder problems in head and neck cancer pa-
tients [10–27]. Most of these studies hypothesized that
performing exercises may prevent or diminish swallowing
[11–16, 21–26] and shoulder problems [17–19, 27]. How-
ever, studies targeting swallowing problems focused on
patients treated with primary (chemo)radiation (except for
two studies [10, 26]), while studies targeting shoulder
problems focused on patients treated with a neck dis-
section with or without (chemo)radiation [17–19, 27].
No studies have primarily focused on patients treated
with TL with or without (chemo)radiation.
Therefore, based on previous experience [28], a guided
self-help program has been developed using a participatory
design approach targeting patients previously treated with
TL. Such a guided self-help program is expected to be
easily accessible for patients and limits burden on time
of healthcare providers [29]. In the first development
phase [30], a needs assessment was performed by means
of one focus group in patients and their partners (n = 9)
and four multidisciplinary meetings with healthcare pro-
fessionals involved in (after)care for patients treated with
TL (n = 11). It was found that a self-help application
should not only include an exercise program, but also
information modules comprising of daily care for the
tracheostomy or voice prosthesis, nutrition, smelling and
speech quality.
In the second phase [30], a prototype of the newly de-
veloped self-help application, including an exercise pro-
gram and self-care education program (i.e. information
modules) was developed. The usability of the self-help
application was evaluated by four patients treated with
TL and ten speech therapists of different head and neck
cancer centers in the Netherlands. Based on these find-
ings, further improvements were made to the application,
which was named “In Tune without Cords (ITwC)”.
Subsequently, the self-care education program of this
final application was tested on its feasibility in a group
of patients that underwent TL up to 2 years ago. It was
found that the usage rate of the self-care education
program was good and patients were satisfied with the
application [31].
The present study aims to investigate the effectiveness
and cost-utility of the guided self-help exercise program
built into ITwC to prevent or diminish speech, swallowing
and neck and shoulder problems in patients treated with
TL. This paper describes the study design, expected re-
sults and benefit of the study.
Methods
Design
This study is a prospective multi-center randomized
controlled trial with two parallel groups, comparing an
intervention group to a control group with equal (1:1)
randomization. Patients will be recruited from various
head and neck cancer centers in the Netherlands in
which TLs are performed. Patients in all participating
centers who are found eligible will be asked to participate
in this study by their treating head and neck surgeon,
speech therapist or nurse specialist/practitioner at the last
consultation prior to discharge, at follow-up visit or by
mail plus telephone. After signing informed consent, pa-
tients will be randomly assigned to the intervention or
control group. The baseline assessment takes place before
randomization, with follow-up assessment immediately
after the intervention or control period (i.e. at 3 months
follow-up) and at 6 months follow-up (Fig. 1). Reasons for
drop-out will be registered. This study has been approved
by the Medical Ethics Committee of the VU University
Medical Center.
Study sample
Patients up to 5 years earlier treated with TL with or with-
out (chemo)radiation will be asked to participate in this
study. The time period of up to 5 years is chosen, since it
is hypothesized that patients recently treated with TL as
well as patients treated longer ago may benefit from the
intervention. Up to 5 years, all patients treated with TL
regularly visit the hospital for follow-up visits. Patients will
be excluded from participation when they are treated with
total laryngectomy combined with total glossectomy, are
treated with a partial laryngectomy, are younger than
18 years, have cognitive impairments, and/or are unable
to understand the Dutch language.
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Randomization
Patients will be randomized to the intervention or control
group by an independent person, stratified for 1) time
since TL (≤6 months after TL vs. > 6 months after TL) to
distinguish patients who are recently treated and who may
in some cases receive postoperative (chemo)radiation from
patients who completed their treatment longer ago; 2)
neck dissection (not treated with a neck dissection versus
treated with a neck dissection); and 3) TL indication
(primary TL or salvage TL) in blocks of two and four
using an automatically created randomization list. Al-
though this is a multicenter study, we chose not to
stratify for study center, because head and neck cancer
care is mainly centered in the University Hospitals in
the Netherlands and highly protocolled via the Dutch
Head and Neck Oncology Cooperative Group (NWHHT).
Patients randomized to the intervention group will be
provided access to the guided self-help exercise program
targeting speech, swallowing and shoulder problems built
into the application ITwC as well as the self-care education
program. Patients randomized to the control group will, in
addition to usual care, also be provided access to the self-
care education program, since we aim to investigate the
effectiveness of the guided self-help exercise program only.
The guided self-help program ITwC will be provided
by Internet [32] or as booklet plus DVD. Patients can
choose themselves between these two formats. Both
formats contain the same content (i.e. the same written
instructions, images and videos are available).
Self-help exercise program
The guided self-help exercise program consist of three
flexibility exercises for head and neck (e.g., turning the
head), four exercises for the shoulders (e.g., raising the
shoulders) and eight range-of-motion exercises for the
tongue, lips, and jaw targeting speech and swallowing
problems (e.g., moving jaw with open mouth) aiming to
prevent or diminish speech, swallowing and shoulder
problems (Fig. 2). In addition, for patients with facial
lymphedema (diagnosed by their head and neck surgeon),
five additional exercises are provided (e.g., massaging the
facial and jaw area).
Patients randomized to the intervention group will be
invited by their speech therapist or nurse practitioner/
specialist for a consultation of half an hour in the hospital
during which the patient will be instructed on how to
perform the prescribed exercises. Following baseline con-
sultation, patients are asked to perform the exercises at
home, three times a day for 12 weeks, using the written
instructions, images and videos of the prescribed exercises
built into the online application of ITwC or a booklet plus
DVD. The prescribed exercises and intensity of the exer-
cises are fixed. The entire exercise protocol takes approxi-
mately 10–15 min a time.
To enhance exercise adherence, patients are asked to fill
out a diary during the 12 week period. In addition, patients
will be coached on a weekly basis by their speech therapist
or nurse practitioner/specialist via e-mail or telephone.
During these coaching sessions, patients will be asked
on their general well-being and exercise performance.
The speech therapist or nurse practitioner/specialist will
take notes of these sessions in order to assess barriers and
facilitators of adherence to the exercise program.
Self-care education program
The self-care education program of ITwC provides infor-
mation and self-care advice on stoma care, voice prosthesis
care, speech, smelling, nutrition and mobility (Fig. 3). The
Eligibility assessment
Exercise program of
12 weeks*
12-weeks of control
care*
Follow-up
measurement
immediately after
the intervention
(i.e. at three
months follow-up)
Follow-up
measurement at
three months
follow-up
Follow-up
measurement at six
months follow-up
Follow-up
measurement at six
months follow-up
Informed consent
Baseline assesment (T0)
Randomization
Fig. 1 Design of the randomized controlled trial
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information and self-care advice are provided in written
text and are supported by several images and videos.
Patients randomized to the intervention and control
group are both provided with the self-care education
program; patients can decide whether they are inter-
ested in using it.
Outcome assessment
For this study, different patient reported outcome mea-
sures will be collected at baseline, immediately after the
intervention or control period (i.e. at 3 months follow-up)
and at 6 months follow-up. Completion of the outcome
measures is expected to take on average 30 min.
Primary outcome measure
The primary outcome measure of this study is the swal-
lowing quality of life questionnaire (SWAL-QOL). The
SWAL-QOL is a 47-item patient-reported outcome meas-
ure that consists of ten different quality of life domains
namely Food selection (two items), Eating duration
(two items), Eating desire (three items), Fear (four
items), Burden (two items), Mental health (five items),
Social functioning (five items), Communication (two
items), Sleep (two items) and Fatigue (three items).
Furthermore, a symptom scale (14 items) is included.
Based on the 30-items of the first seven mentioned
quality of life domains a total SWAL-QOL score can be
calculated. All SWAL-QOL scales range from 0 to 100,
a higher score indicates more impairment. Finally, three
separate questions on nutrition intake (normal, soft,
pureed, mostly tube feeding, only liquids, tube feeding
solely), liquids intake (all liquids, thick liquids, very
thick liquids, thickened liquids, no liquids), and general
health (poor, moderate, good, very good, excellent) are
included. The SWAL-QOL has been translated into
Dutch and validated for patients with head and neck
cancer [33] and laryngeal cancer [8].
Secondary outcome measures
Secondary outcome measures of this study are the speech
handicap index (SHI), the shoulder disability questionnaire
(SDQ), the European Organization for Research and
Fig. 2 Screenshot self-help exercise program
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Treatment of Cancer generic and head and neck cancer
specific quality of life measures (EORTC QLQ-C30 and
EORTC QLQ-H&N35) and the Patient Activation Measure
(PAM). In addition, the EuroQol-5 dimensions (EQ-5D)
and patient-reported outcome measures on healthcare
usage and productivity losses will be assessed to enable
a cost-utility analysis.
The SHI is a 30-item patient reported outcome measure
on speech problems in daily life. Response categories range
on a five point scale (never, almost never, sometimes,
almost always, always). In addition, the questionnaire in-
cludes an overall speech quality item, with four response
categories (good, reasonable, poor, severe). A total SHI
score can be calculated by summing all items (score ranges
from 0 to 120), with higher scores indicating higher levels
of speech-related problems. The SHI had been translated
into Dutch and validated for use among head and neck
cancer patients [34] and laryngeal cancer patients [8].
The SDQ is a validated pain related disability outcome
measure including 16 items describing common condi-
tions that may induce symptoms in patients with disorders
of the shoulder [35]. All items refer to the preceding 24 h.
Options are “yes”, “no” and “not applicable”. The “not
applicable” category should be used when the condition
referred to has not occurred during the preceding 24 h. A
final score will be calculated by dividing the number of
“yes” scored items by the total number of items applicable
and multiplying this score by 100. The final score
ranges from 0 (no disability) to 100 (all applicable items
scored “yes”), in which a higher score indicates greater
impairment.
The EORTC QLQ-C30 is a cancer-specific quality of
life measure developed for repeated assessments within
clinical trials. It is developed in a cross-cultural setting
and is a valid and reliable instrument for quality of life
assessments in various cancer populations, including
head and neck cancer patients [36]. It contains five func-
tional scales (physical, cognitive, emotional, social, role),
a global quality of life scale, three symptom scales (pain,
fatigue and nausea/vomiting) and six single items (dys-
pnoea, insomnia, loss of appetite, constipation, diarrhea
and financial difficulties). All scales and single items can
be converted to a score from 0 to 100. A higher score
on the functioning scales or the global quality of life
Fig. 3 Screenshot self-care education program
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scale represents a better quality of life, whereas a higher
score on the symptoms scales or the single items indi-
cate higher level of symptoms.
The EORTC QLQ-H&N35 is a cancer-specific module
developed for quality of life assessments in head and neck
cancer patients [37] in conjunction with the EORTC QLQ-
C30. It contains seven symptom scales (pain, swallowing,
senses, speech, social eating, social contact and sexuality),
six symptom items (teeth, trismus, dry mouth, sticky saliva,
cough and feeling ill) and five additional items concerning
the use of painkillers, nutritional supplements and feeding
tube and weight loss or gain. All scales and single items
range in score from 0 to 100, higher scores indicate a
higher level of symptoms.
The PAM is a 13-item patient reported outcome meas-
ure on self-reported knowledge, skills and confidence for
self-management of one’s health or chronic condition [38].
Patients are asked to report their level of agreement with
various statements on a four point scale (e.g. strongly dis-
agree, disagree, agree, strongly agree) or to indicate that
the item was not applicable. A total score can be calculated
by calculating a mean score of all the applicable items
(items which were answered on the four point scale),
which is transformed to a standardized activation score
ranging from 0 to 100.
The EQ-5D consists of five items measuring problems
on five dimensions of quality of life (mobility, self-care,
usual activities, pain/discomfort and anxiety/depression).
Patients can answer they have no problems, some prob-
lems or extreme problems [39]. The resulting profile of
answers (one of 243 possibilities) can be transformed to
a utility given by the general public: the EQ-5D index
using the Dutch index tariff [40]. Furthermore, a visual
analogue scale is included, which represents the patient’s
judgment of his own health state on a scale from 0
(worst health state) to 100 (best health state).
Direct medical (healthcare and medication use), direct
non-medical (travelling costs and help received from
family or friends) and indirect non-medical costs (product-
ivity losses) in the previous 3 months will be measured
using an adapted version of the medical consumption ques-
tionnaire (iMCQ) [41] and productivity cost questionnaire
(iPCQ) [42] of the Institute for Medical Technology
Assessment of the Erasmus University Rotterdam, the
Netherlands, as recommended in the Dutch Health
Care Insurance Board (CVZ) guideline [43].
Sociodemographic and medical data
Sociodemographic characteristics (age, gender, education
level and living situation) will be assessed at baseline
using a study-specific questionnaire. Clinical characteristics
including information on cancer stage (TNM classification)
and cancer treatment, time since TL and co-morbidity will
be collected from the hospital information system using a
study-specific case report form. Co-morbidity will be
measured using the Adult Comorbidity Evaluation 27
(ACE-27), in which patients can be classified into one
of four grades of comorbidity (none, mild, moderate or
severe) [44]. Besides, a case report form on health care
use in the hospital during the study period, including
visits to medical specialists, day treatment (e.g. chemo-
therapy) and hospital admission, will be completed using
the hospital information system.
Sample size
In a previous study of Rinkel et al. [8] a standard deviation
of 21 on the SWALQOL, the primary outcome measure
in this study, was found. In addition, a difference in im-
provement of 12 points was found to be clinically mean-
ingful. Based on a power of 80 %, a significance level of
5 % and a standard deviation of 21, in total 100 patients
are needed (50 patients per intervention arm), to demon-
strate a difference in improvement of 12 points between
the intervention and control group at 6 months follow-up.
Results will be analyzed according to the intention-to-
treat principle and all drop-outs, when possible, will be
approached for follow-up measurements.
Statistical analyses
All analyses will be performed using the IBM Statistical
package for the Social Science (SPSS) version 22 (IBM
Corp., Armonk, NY USA) and STATA version 12.1
(StataCorp LP, Texas, USA). Descriptive statistics (e.g.
frequencies, percentages, means and standard deviations
or medians and (interquartile) ranges) will be generated
for all socio-demographic and clinical characteristics and
outcome measures. Chi-square tests, independent t-tests
and Mann-Whitney tests (in case of non-normality of the
measure) will be used to analyze whether randomization
resulted in comparable patient groups. Analyzes will be
performed according to the intention-to-treat principle. A
p-value < .05 will be considered significant.
Independent t-tests will be used to measure differences in
swallowing quality (SWAL-QOL), speech quality (SHI),
shoulder function (SDQ) and quality of life (EORTC QLQ-
C30 and H&N35) between the intervention and control
group at follow-up measurements. Linear mixed models
and generalized estimating equations, with fixed effects for
group and measurement and their two-way interaction and
a random effect for subject, will be used to compare longi-
tudinal changes in both groups over time.
An incremental cost utility ratio (ICUR) will be calcu-
lated measuring the cost per gained quality-adjusted life
year (QALY). The ICUR will be calculated by dividing the
incremental costs by the incremental QALYs, using the
formula: ICUR = (Cint - Ccon)/(QALYint - QALYcon). Total
costs will be calculated using a societal perspective,
including intervention costs, direct medical, direct non-
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medical and indirect non-medical costs. Direct medical
and non-medical costs will be calculated by multiplying
resource use by integral cost prices as presented in the
CVZ guideline on cost studies [43]. Indirect non-medical
costs will be calculated using the friction cost approach as
recommended in the CVZ guideline [43]. Total QALYs
will be calculated by using the utility scores linked to the
various health states of the EQ-5D [40]; in essence the
length of time a patient spends in a particular health con-
dition is weighed by the corresponding utility. Missing
data on direct medical, direct non-medical and indirect
non-medical costs measured using the cost questionnaire
and utilities measured using the EQ-5D will be imputed
using multiple imputation. If necessary, the estimates of
the cost difference, the QALY difference and the ICUR
will be corrected for differences in baseline characteristics
between the two groups. Since follow-up of the study is
less than 1 year, we will neither discount costs nor effects.
To assess uncertainty surrounding the findings, 5000
bootstrapped replications will be calculated and presented
on a cost-utility plane. In addition, ICUR acceptability
curves will be presented and sensitivity analyses will be
performed focusing on uncertainty surrounding most
important cost items.
Discussion
This study aims to investigate the effectiveness and cost-
utility of a guided self-help exercise program to prevent
or diminish speech, swallowing and neck and shoulder
problems in patients treated with TL. Targeting these
problems in patients treated with TL is of importance,
since a major group of patients report such problems,
which impact their quality of life and daily life [3–9].
Patients randomized to the guided self-help exercise
program in our study will be asked to perform different
flexibility exercises three times a day for 12 weeks. Based
on a previous study in head and neck cancer patients
undergoing (postoperative) (chemo)radiation [28], the
guided self-help exercise program of ITwC is hypothe-
sized to be feasible. In this study of Cnossen et al. [28],
uptake of the exercise program “Head Matters” was high
(i.e. 83 %) and adherence (i.e. patients exercising at least
once a day during their treatment period) was adequate
(i.e. 64 %).
The guided self-help exercise program evaluated in the
present study is hypothesized to prevent or diminish speech,
swallowing and neck and shoulder problems in patients
treated with TL. Previous randomized controlled trials have
shown beneficial findings of an exercise program in head
and neck cancer patients [11, 15, 17–19, 23–25, 27]. One
randomized controlled trial in head and neck cancer
patients on the effectiveness of an exercise program
consisting of five prophylactic swallowing exercises
throughout (chemo)radiation showed beneficial effects
on functional oral intake, eating in public and normalcy
of diet compared to usual care [15]. Usual care involved
referral to a speech therapist if swallowing problems were
present after completion of (chemo)radiation. Besides,
three randomized controlled trials on the effectiveness of
an exercise program that included device-based (i.e. Ther-
abite) exercises showed beneficial effects on residue after
swallowing [24], maintenance of muscle composition [11],
mouth opening [11, 23], salivary flow [11], tube depend-
ency [11], trismus [23] and swallowing function [11, 23] in
head and neck cancer patients compared to control care.
In addition, previous trials in head and neck cancer pa-
tients treated with a neck dissection in general showed
beneficial effects of progressive resistance exercises target-
ing shoulder functioning on shoulder rotation [17, 19, 27],
shoulder pain and disability [17, 19], muscular endurance
and strength [17].
However, a recent randomized controlled trial by
Mortensen et al. [20] did not find any beneficial effect
of a swallowing exercise program consisting of seven
prophylactic swallowing exercises combined with standard
individualized dietary advice among head and neck cancer
patients. Potential explanations that were reported for the
lack of beneficial effects may be the low to moderate ad-
herence rate to the exercises and the limited statistical
power due to high drop-out rates.
Although some studies thus have already been performed
on the effectiveness of exercise programs in a heteroge-
neous group of head and neck cancer patients, the results
are inconclusive. Our study is expected to add important
information to the above mentioned literature. At first, our
study will provide information on the beneficial effects in a
more homogeneous group of head and neck cancer pa-
tients, namely patients treated with TL. As reported in
the introduction section, patients treated with TL were
often not included in previous studies and, consequently,
previous findings may not be representable for patients
treated with TL. In addition, our study combines exercises
for speech, swallowing and neck and shoulder problems in
one exercise program, thereby targeting the prevention or
treatment of speech, swallowing as well as neck and shoul-
der problems in patients treated with TL, while previous
programs only targeted swallowing or shoulder problems.
Another strength of our study is that special attention will
be paid to improving adherence to the guided self-help ex-
ercise program. Patients will be asked to fill in a diary on
the number of times practiced each day and will be con-
tacted on a weekly basis by the speech pathologist or nurse
practitioner/specialist by e-mail or telephone in order to
motivate the patient and ask the patient on his/her exercise
performance. Furthermore, due to these weekly contact
moments in combination with the provision of written in-
structions, images and videos of the prescribed exercises
and the relatively easy to learn exercises which bring
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negligible risks, patients only have to visit the medical
center once for instructions on the prescribed exercises.
This will possibly reduce drop-out of patients of the guided
self-help exercise program.
In addition to focusing on clinical effectiveness, this
study will also evaluate the cost-utility of a guided self-
help exercise program. One previous study by Retèl et al.
[45] reported on the cost-utility of a preventive swallowing
exercise program and found that the exercise program
had a probability of 83 % to be cost-effective at a willing-
ness to pay value of €20,000/QALY. Performing economic
evaluations are of importance, since this provides know-
ledge on the value for money of health care interventions,
which is important knowledge when deciding on the
implementation of interventions in clinical practice. A po-
tential limitation of this study may be that patients in the
control group were provided with the self-care education
program of ITwC, while no control group without inter-
vention was included. This design was chosen, since we
did want to give all TL patients the opportunity to benefit
from the self-care education program. Since we aimed to
assess the effectiveness and cost-utility of the guided self-
help program on speech, swallowing and shoulder prob-
lems specifically, and the self-care education program is
not expected to influence these outcomes, this is not ex-
pected to be harmful.
Ethics and dissemination
This study will be conducted according to the principles
of the Declaration of Helsinki (version, October 2013)
and in accordance with the Medical Research Involving
Human Subjects Act (WMO). Risks of participation in
this study are negligible.
If this guided self-help exercise program is (cost)effective
for patients treated with TL, the next step will be to focus
on implementation of this program in clinical practice. The
collaboration with the Dutch Head and Neck Oncology
Cooperative Group (NWHHT) [46] for this study and the
involvement of the patients association for patients treated
with TL (NSvG) [47] in the development process is ex-
pected to facilitate implementation of the guided self-help
exercise program in clinical care. The NWHHT, the
Paramedical Dutch Head and Neck Oncology Cooperative
Group (PWHHT) and the NSvG will be informed about
the findings of this study in order to facilitate implementa-
tion of this intervention in all centers in which patients
with TL are treated. In addition, guideline committees will
be informed and advised to adapt (inter)national guide-
lines on laryngeal cancer. Also, results will be published in
peer-reviewed scientific journals.
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